Good morning :)
Place Order
Add to Watchlist

Ishita Drugs and Industries Ltd

ISHITADR Share Price

84.000.08% (+0.07)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹25 cr, stock is ranked 4,075

High Risk

Stock is 4.30x as volatile as Nifty

ISHITADR Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹25 cr, stock is ranked 4,075

High Risk

Stock is 4.30x as volatile as Nifty

ISHITADR Performance & Key Metrics

ISHITADR Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
28.852.53—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.516.490.83%

ISHITADR Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

ISHITADR Company Profile

Ishita Drugs And Industries is engaged in the manufacturing of various active pharma ingredients, drug intermediates, excipients and fine chemicals.

ISHITADR Similar Stocks (Peers)

Compare with peers Compare with peers 

ISHITADR Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
36.83
36.83
1Y Return
9.50%
9.50%
Buy Reco %
87.88
87.88
Cipla Ltd
CIPLA
PE Ratio
22.94
22.94
1Y Return
1.68%
1.68%
Buy Reco %
73.33
73.33
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
59.32
59.32
1Y Return
17.50%
17.50%
Buy Reco %
70.83
70.83
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
18.70
18.70
1Y Return
0.48%
0.48%
Buy Reco %
55.17
55.17
Zydus Lifesciences Ltd
ZYDUSLIFE
PE Ratio
22.13
22.13
1Y Return
8.75%
8.75%
Buy Reco %
44.44
44.44
Compare with Peers

ISHITADR Forecast

ISHITADR Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

ISHITADR

ISHITADR

Income

Balance Sheet

Cash Flow

ISHITADR Income Statement

ISHITADR Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 0.45%, vs industry avg of 10.2%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.01% to 0%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 9.75%, vs industry avg of 20.11%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue6.527.029.2514.9914.2614.2012.2715.4715.3315.33
Raw Materialssubtract3.844.866.2711.4510.2010.208.6911.4414.0013.99
Power & Fuel Costsubtract0.200.200.240.240.240.230.170.16
Employee Costsubtract0.450.560.670.760.760.760.770.83
Selling & Administrative Expensessubtract0.680.650.871.131.301.441.481.67
Operating & Other expensessubtract0.910.170.520.490.530.370.210.18
Depreciation/Amortizationsubtract0.140.140.160.180.150.130.130.110.110.12
Interest & Other Itemssubtract0.040.110.060.030.030.020.050.090.070.07
Taxes & Other Itemssubtract0.080.080.120.170.220.240.200.240.290.28
EPS0.600.841.141.812.782.711.912.512.902.91
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00
See Costs

ISHITADR Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

ISHITADR Stock Peers

ISHITADR Past Performance & Peer Comparison

ISHITADR Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation-basic on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Ishita Drugs and Industries Ltd29.182.53—
Sun Pharmaceutical Industries Ltd36.836.000.95%
Cipla Ltd22.943.871.07%
Torrent Pharmaceuticals Ltd59.3216.530.96%

ISHITADR Stock Price Comparison

Compare ISHITADR with any stock or ETF
Compare ISHITADR with any stock or ETF
ISHITADR
Loading...

ISHITADR Holdings

ISHITADR Shareholdings

ISHITADR Promoter Holdings Trend

ISHITADR Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

ISHITADR Institutional Holdings Trend

ISHITADR Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

ISHITADR Shareholding Pattern

ISHITADR Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding49.91%0.00%0.00%0.00%50.09%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

ISHITADR Shareholding History

ISHITADR Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

ISHITADR Insider Trades & Bulk Stock Deals

ISHITADR Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing ISHITADR stock

smallcases containing ISHITADR stock

Looks like this stock is not in any smallcase yet.

ISHITADR Events

ISHITADR Events

ISHITADR Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

ISHITADR has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

ISHITADR Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

ISHITADR has not given any dividends in last 5 years

ISHITADR Dividends

ISHITADR Dividends

Hmm, looks like data is unavailable here. Please come back after some time

ISHITADR Stock News & Opinions

ISHITADR Stock News & Opinions

Corporate
Ishita Drugs & Industries to hold board meeting

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 13 June 2025.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Ishita Drugs & Industries standalone net profit rises 3.57% in the March 2025 quarter

Net profit of Ishita Drugs & Industries rose 3.57% to Rs 0.29 crore in the quarter ended March 2025 as against Rs 0.28 crore during the previous quarter ended March 2024. Sales rose 1.33% to Rs 4.56 crore in the quarter ended March 2025 as against Rs 4.50 crore during the previous quarter ended March 2024. For the full year,net profit rose 16.00% to Rs 0.87 crore in the year ended March 2025 as against Rs 0.75 crore during the previous year ended March 2024. Sales declined 1.25% to Rs 15.00 crore in the year ended March 2025 as against Rs 15.19 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales4.564.50 1 15.0015.19 -1 OPM %6.366.67 -6.675.99 - PBDT0.410.38 8 1.271.10 15 PBT0.380.37 3 1.160.99 17 NP0.290.28 4 0.870.75 16 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Ishita Drugs & Industries to table results

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Ishita Drugs & Industries standalone net profit rises 100.00% in the December 2024 quarter

Net profit of Ishita Drugs & Industries rose 100.00% to Rs 0.24 crore in the quarter ended December 2024 as against Rs 0.12 crore during the previous quarter ended December 2023. Sales rose 28.66% to Rs 4.13 crore in the quarter ended December 2024 as against Rs 3.21 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales4.133.21 29 OPM %7.266.85 - PBDT0.350.19 84 PBT0.320.16 100 NP0.240.12 100 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Ishita Drugs & Industries schedules board meeting

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 13 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Ishita Drugs & Industries standalone net profit declines 9.52% in the September 2024 quarter

Net profit of Ishita Drugs & Industries declined 9.52% to Rs 0.19 crore in the quarter ended September 2024 as against Rs 0.21 crore during the previous quarter ended September 2023. Sales declined 25.68% to Rs 3.27 crore in the quarter ended September 2024 as against Rs 4.40 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales3.274.40 -26 OPM %7.035.00 - PBDT0.280.31 -10 PBT0.250.28 -11 NP0.190.21 -10 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Ishita Drugs & Industries to conduct board meeting

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Ishita Drugs & Industries AGM scheduled

Ishita Drugs & Industries announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live
Earnings
Ishita Drugs & Industries standalone net profit rises 7.14% in the June 2024 quarter

Net profit of Ishita Drugs & Industries rose 7.14% to Rs 0.15 crore in the quarter ended June 2024 as against Rs 0.14 crore during the previous quarter ended June 2023. Sales declined 1.94% to Rs 3.03 crore in the quarter ended June 2024 as against Rs 3.09 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales3.033.09 -2 OPM %5.945.83 - PBDT0.230.22 5 PBT0.200.19 5 NP0.150.14 7 Powered by Capital Market - Live

10 months agoCapital Market - Live
Corporate
Ishita Drugs & Industries to declare Quarterly Result

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Ishita Drugs and Industries Ltd (ISHITADR) today?

    The share price of ISHITADR as on 3rd July 2025 is ₹84. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Ishita Drugs and Industries Ltd (ISHITADR) share?

    The past returns of Ishita Drugs and Industries Ltd (ISHITADR) share are
    • Past 1 week: -1.22%
    • Past 1 month: 11.36%
    • Past 3 months: -0.72%
    • Past 6 months: -12.82%
    • Past 1 year: 27.62%
    • Past 3 years: 81.03%
    • Past 5 years: 418.52%

  3. What are the peers or stocks similar to Ishita Drugs and Industries Ltd (ISHITADR)?

    The peers or stocks similar to Ishita Drugs and Industries Ltd (ISHITADR) include:

  4. What is the market cap of Ishita Drugs and Industries Ltd (ISHITADR) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ishita Drugs and Industries Ltd (ISHITADR) is ₹25.10 Cr as of 3rd July 2025.

  5. What is the 52 week high and low of Ishita Drugs and Industries Ltd (ISHITADR) share?

    The 52-week high of Ishita Drugs and Industries Ltd (ISHITADR) is ₹104.75 and the 52-week low is ₹62.35.

  6. What is the PE and PB ratio of Ishita Drugs and Industries Ltd (ISHITADR) stock?

    The P/E (price-to-earnings) ratio of Ishita Drugs and Industries Ltd (ISHITADR) is 29.18. The P/B (price-to-book) ratio is 2.53.

  7. Which sector does Ishita Drugs and Industries Ltd (ISHITADR) belong to?

    Ishita Drugs and Industries Ltd (ISHITADR) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Ishita Drugs and Industries Ltd (ISHITADR) shares?

    You can directly buy Ishita Drugs and Industries Ltd (ISHITADR) shares on Tickertape. Simply sign up, connect your demat account and place your order.